JI Silverberg - Dermatologic clinics, 2017 - derm.theclinics.com
AD is a chronic inflammatory skin disease affecting both children and adults. AD is associated with a substantial public health burden secondary to high prevalence in many …
Background Dupilumab, a human monoclonal antibody against interleukin-4 receptor alpha, inhibits signaling of interleukin-4 and interleukin-13, type 2 cytokines that may be important …
M de Bruin‐Weller, D Thaçi, CH Smith… - British Journal of …, 2018 - academic.oup.com
Background Atopic dermatitis is a chronic inflammatory skin disease that may require systemic therapy. Ciclosporin A (CsA) is a widely used, potent immunosuppressant but it is …
Background Data from early-stage studies suggested that interleukin (IL)-4 and IL-13 are requisite drivers of atopic dermatitis, evidenced by marked improvement after treatment with …
LF Eichenfield, WL Tom, SL Chamlin… - Journal of the American …, 2014 - Elsevier
Atopic dermatitis (AD) is a chronic, pruritic, inflammatory dermatosis that affects up to 25% of children and 2% to 3% of adults. This guideline addresses important clinical questions that …
EL Simpson, JR Chalmers, JM Hanifin… - Journal of Allergy and …, 2014 - Elsevier
Background Atopic dermatitis (atopic eczema) is a chronic inflammatory skin disease that has reached epidemic proportions in children worldwide and is increasing in prevalence …
Background Atopic dermatitis (AD) has been associated with anxiety and depression, but the magnitude of the alleged association is unknown. Objective To perform a systematic …
Atopic dermatitis comorbidities extend well beyond the march to allergic conditions (food allergy, asthma, allergic rhinitis, allergic conjunctivitis, and eosinophilic esophagitis) …